$7.79
0.121.56%
At close: -
$8.00
0.212.70%
After Hours: Mar 27, 9:26 AM EDT
Elicio Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Elicio Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ELTX | Elicio Therapeutics | -$1.15 | -$0.82 | — | — | $0.00 | — | — | — | 05/14/2025 | Get Alert |
ELTX | Elicio Therapeutics | -$3.77 | -$0.88 | — | — | $0.00 | — | — | — | 04/08/2025 | Get Alert |
ELTX | Elicio Therapeutics | -$1.27 | -$0.81 | -$1.39 | -71.60% | $0.00 | — | $0.00 | — | 11/13/2024 | Get Alert |
ELTX | Elicio Therapeutics | -$2.61 | -$0.96 | -$0.64 | 33.33% | $0.00 | — | $0.00 | — | 08/13/2024 | Get Alert |
ELTX | Elicio Therapeutics | -$24.77 | -$1.21 | -$1.15 | 4.96% | $0.00 | — | $0.00 | — | 05/15/2024 | Get Alert |
ELTX | Elicio Therapeutics | — | -$0.78 | -$3.77 | -383.33% | — | — | $0.00 | — | 03/29/2024 | Get Alert |
ELTX | Elicio Therapeutics | -$22.67 | — | -$1.27 | — | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
ELTX | Elicio Therapeutics | -$23.20 | — | -$2.61 | — | $0.00 | — | $0.00 | — | 08/11/2023 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-13 | $-1.39 | $-0.81 | -71.6 % |
Q2 | 2024-08-13 | $-0.64 | $-0.96 | 33.3 % |
Q1 | 2024-05-15 | $-1.15 | $-1.21 | 4.96 % |
Q4 | 2024-03-29 | $-3.77 | $-0.78 | -383.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Elicio Therapeutics (ELTX) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-1.39, which missed the estimate of $-0.81.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.